Abstract. The discovery, about forty years ago, of a -bungarotoxin, a three-finger a -neurotoxin from Bungarus multicinctus venom, enabled the isolation of the nicotinic acetylcholine receptor (nAChR), making it one of the most thoroughly characterized receptors today. Since then, the sites of interaction between a -neurotoxins and nAChRs have largely been delineated, revealing the remarkable plasticity of the three-finger toxin fold that has optimally evolved to utilize different combinations of functional groups to generate a panoply of target specificities to discern subtle differences between nAChR subtypes. New facets in toxinology have now broadened the scope for the use of a-neurotoxins in scientific discovery. For instance, the development of short, combinatorial library-derived, synthetic peptides that bind with subnanomolar affinity to a -bungarotoxin and prevent its interaction with muscle nAChRs has led to the in vivo neutralization of experimental a -bungarotoxin envenomation, while the successful introduction of pharmatopes bearing "a -bungarotoxin-sensitive sites" into toxin-insensitive nAChRs has permitted the use of various a -neurotoxin tags to localize and characterize new receptor subtypes. More ambitious strategies can now be envisaged for engineering rationally designed novel activities on three-finger toxin scaffolds to generate lead peptides of therapeutic value that target the nicotinic pharmacopoeia. This review details the progress made towards achieving this goal.
1. Animal toxins: key players in science and medicine It will be an interesting paradox if it transpires that the venomous creatures that have so long been reviled by the human race turn out to provide key lessons for revolutions in medicine (and science), which prolong and enhance human existence.
Mark J. Dufton (1993) 
1).
In the course of their long evolutionary history, snakes and other venomous animals have created innovative and intricate protein structural motifs to generate a vast resource of pharmacologically novel peptide toxins that target a wide variety of receptors and ion channels with high affinity and specificity. The specificity of some toxins is so exquisite that they are capable of discriminating subtle differences in binding sites on a single receptor population, like the binding sites located at the interfaces of the a1 / g or a1/ d subunits in the muscle (a 1) 2 b1gd nicotinic acetylcholine receptor (nAChR) (2) . Although early venom research was motivated by our desire for satisfactory cures for snake envenomation, our perspectives on animal toxins have changed dramatically due to accumulating data that has revealed a far wider scope for these natural biomolecules, which have assumed great significance as molecular probes and pharmacological tools to investigate the functional biology of receptors and ion channels as well as providing lead compounds for the design of clinically useful drugs (3 -5) .
There is perhaps no better example to highlight the significant contributions made by venom peptides to science and medicine than the discovery, about forty years ago, of the curaremimetic neurotoxin, a -bungarotoxin, from the venom of the Taiwanese many-banded krait (Bungarus multicinctus) (6) , which spawned the field of molecular pharmacology (7) by enabling the isolation and study of the nAChR from the electric organ of the electric eel and other sources (8, 9) . The discovery of a -bungarotoxin and orthologues from other species also enabled the localization of the nAChR in situ and identification of subtypes of the receptor in various muscle and neural tissues (2) , making the nAChR one of the most thoroughly characterized receptors today (10).
Snake envenomation: nefarious role of neurotoxins
Snake venoms are a cocktail of toxins and enzymes that have optimally evolved as a lethal weapon for predation as well as defense against predators. Depending on the species, snake envenomation in humans may result in peripheral neurotoxicity, coagulative disorders, myotoxicity, renal failure as well as severe necrosis at the site of the bite, all of which can be potentially fatal (11) . Snake envenomation is a major clinical problem with over 2.5 million cases of snake bites reported worldwide, particularly in parts of the Asian region and Africa where the annual mortality is estimated to be 100,000 and 20,000, respectively (12) . One of the primary targets of snake venom is the peripheral nervous system, the skeletal muscle neuromuscular junction in particular, where neurotransmission is inhibited, leading to paralysis of skeletal muscles including those of respiration (11) . Clearly therefore, the study of the interaction of snake venom toxins with the skeletal muscle neuromuscular junction is also of great clinical significance.
Snake toxins that affect cholinergic neurotransmission
The arsenal of snake neurotoxins that interfere with cholinergic neurotransmission consists of a wide variety of toxins that target multiple subtypes of both nicotinic and muscarinic acetylcholine receptors at peripheral as well as central sites. Often, a combination of many types of neurotoxins may be present together in the venom of one species. The principal neurotoxic components of Elapid (cobras, kraits, mambas, coral snakes, and Australian elapids) and Hydrophiid (sea snakes) snake venoms are neurotoxins that bind to postsynaptic nAChRs at the skeletal muscle neuromuscular junction to produce blockade of neuromuscular transmission (9, 13, 14) . These neurotoxins, referred to as curaremimetic or a-neurotoxins, will be the subject of this review.
The skeletal muscle neuromuscular junction is also susceptible to neurotoxin action at presynaptic sites. Presynaptic neurotoxins (e.g., b-bungarotoxin (Bungarus multicinctus)) are either phospholipase A 2 enzymes or contain these enzymes as an integral part of the neurotoxin complex and, essentially, mediate their neurotoxicity by inhibiting the release of acetylcholine (13, 15, 16) . Other neurotoxins that interfere with cholinergic neurotransmission include fasciculins from mamba (Dendroaspis spp.) venoms that inhibit the activity of acetylcholinesterase present at the neuromuscular junction as well as at central synapses (17) and k-neurotoxins (Bungarus spp.), which bind to neuronal a3b2 as well as other nAChRs composed of b2 subunits (18, 19) . Several muscarinic toxins have also been isolated from mamba venoms (Dendroaspis spp.), which are antagonists or agonists at various subsets of muscarinic receptors in the brain as well as at peripheral sites (20 -23) .
4. Curaremimetic a-neurotoxins: more than just a case of mimicry "The designation of a -and b-bungarotoxin were simply based on the moving velocity of the toxins through a potato starch electrophoresis preparation during their purification and it was not my intention to use the suffix a -to designate a postsynaptic site of action. However, I found it amazing that, as if to follow conformity, toxins isolated thereafter and found to manifest postsynaptic effects were also named with this suffix" C.C. Chang (1999) (Ref. 24) Curaremimetic or a -neurotoxins interfere with cholinergic transmission at the skeletal muscle neuromuscular junction by binding with high affinity and selectivity to postsynaptic nAChRs to produce blockade of neuromuscular transmission (9, 13, 14, 24, 25) . These toxins, which mimic the neuromuscular blocking effects of the plant alkaloid (+)-tubocurarine, but with approximately 15 -20-fold greater affinity and poor reversibility of action, are referred to as curaremimetic neurotoxins or postsynaptic neurotoxins to reflect their postjunctional site of action at the neuromuscular junction (13) or simply as a -neurotoxins, a suffix of historical significance (24) . Most a -neurotoxins are derived from Elapidae or Hydrophiidae snake venom and belong to the three-finger toxin family. Well-known examples of such toxins include a -bungarotoxin (Bungarus multicinctus) and erabutoxin-b (Laticauda semifasciata) (Fig. 1) . The only interesting exception are the waglerins, isolated from the venom of the Wagler's pit viper (Tropidolaemus wagleri (Viperidae)), which are 22 -24-residues-long and contain a single disulfide bridge and in addition, show remarkable selectivity for the a 1 / e over the a 1 / g and a 1/ d interfaces of the mouse muscle nAChR (7) .
It must be emphasised that snake venoms are not the exclusive source of a -neurotoxins. The venoms of marine cone snails also represent a rich combinatoriallike library of evolutionarily selected, neuropharmacologically active peptides called conotoxins that target a wide variety of receptors and ion-channels. In particular, a-conotoxins are short (approximately 12 -30-residueslong) disulfide-rich peptides that are capable of discriminating between the different ligand-binding interfaces of the muscle nAChR as well as some that are Fig. 1 . The 3D-structures of three-finger neurotoxins from snake venoms that interact with nicotinic acetylcholine receptors. The three-dimensional structures are shown in similar orientation and in line ribbon representation. Disulfide bridges are shown in black. The species names and the Protein Data Bank accession codes for structures are as follows: A: Erabutoxin-a (Laticauda semifasciata) 5EBX, B: Toxin-a (Naja nigricollis) 1NEA, C: Candoxin (Bungarus candidus) 1JGK, D: Bucandin (Bungarus candidus) 1F94, E: a-Cobratoxin (Naja kaouthia) 2CTX, F: a-Bungarotoxin (Bungarus multicinctus) 1IK8, G: LSIII (Laticauda semifasciata) 1LSI, and H: k -Bungarotoxin (Bungarus multicintus) 2NBT. All are averaged NMR structures except erabutoxin-a, 2.0-Å crystal structure and a-cobratoxin, 2.4-Å-crystal structure.
selective for various subtypes of neuronal nAChRs; this is a remarkable feat given their small and compact disposition (reviewed in 26 -30) .
a-Neurotoxins bear the imprint of a region of the nAChR that is likely to be in proximity to, and perhaps even overlap, the binding site for the natural neurotransmitter acetylcholine (25) . The pharmacological and structural characterization of this important region of the nAChR will greatly enhance our understanding of how these, and perhaps other ligand-gated ion-channels, work.
5. Nicotinic acetylcholine receptors: on a roll "The nicotinic acetylcholine receptor, as a result of the combined contributions of electrogenic fish, Elapid snakes and many talented scientists, became the first neurotransmitter receptor to be characterized, purified and cloned" Brian Molles and Palmer 
The nAChR is perhaps one of the best characterized ion-channel to date, due in part to the discovery of abungarotoxin and a rich and accessible source of receptor from the electric ray and eel. Consequently, the mammalian neuromuscular junction is also the most studied and best understood synapse (31 -33) . The nAChRs are transmembrane allosteric proteins of MW approximately 290 kDa that are involved in fast ionic responses to acetylcholine (10, 34, 35) . They are pentamers formed by the association of five subunits arranged symmetrically around the ionic pore in a plane perpendicular to the membrane (Fig. 2: A and B) (35, 36) . Each subunit is composed of a large amino-terminal domain that contributes to the formation of the ligand binding pocket; four membrane-spanning domains (MI, MII, MIII, MIV); a large and variable cytoplasmic loop between MIII and MIV; and a small extracellular carboxyl terminal. The MII domains of all five subunits contribute to the formation of the cation channel pore (Fig. 2: A and B) . In vertebrates, the combinatorial assembly of various nicotinic receptor subunits (a 1 -a 10, b1 -b4, d , g, or e) generates a wide diversity of receptors, with various electrical and binding properties. Very broadly, nicotinic receptors can be divided into two main families: the muscle and neuronal nAChRs (34) . The well-characterized muscle receptor consists of a combination of a 1, b1, d , and g or e subunits in the stoichiometry of (a 1) 2 b1gd or (a 1) 2 b 1ed in the embryonic or adult receptor, respectively. These are densely distributed on the postsynaptic membrane of the neuromuscular junction and mediate intercellular communication between the nerve ending and skeletal muscle. The muscle-type receptor (a 1) 2 b 1gd is also found in abundance in the electric organ of the Torpedo ray. Neuronal nicotinic receptors are composed of a 2 -a10 and b2 -b4 subunits.
The extracellular amino-terminal domains of nAChRs are approximately 210 amino-acid-residues-long and contain binding sites for agonists and competitive antagonists. The ligand-binding site is located at the interface between two subunits with contributions from both counterparts (34, 37) . The principal part of the binding pocket is formed by the a 1-subunit residues contributing to loops A, B, and C, whereas the neighboring subunit (d , g, or e in muscle nAChR) residues contribute to loops D, E and F that form the complementary part of the binding pocket (34, 37, 38) . Thus, the muscle nAChR contains two different ligand-binding sites (a 1 / d and a 1 / g or a 1/ e) with distinct affinities for nicotinic antagonists (34) .
An excellent insight into the structure of nAChRs, and ligand-gated ion channels in general, was made possible by the discovery and characterization of an acetylcholine-binding protein from the snail Lymnaea stagnalis (Fig. 2 : B and C) (39, 40) which is a remarkable homologue of the amino-terminal extracellular domain of the nAChR. The crystal structure of the acetylcholine binding protein at 2.7 Å resolution revealed that each ligand-binding site is located in a cleft at the subunit interface, formed by a series of loops (A, B, and C) from the principal face of one subunit and another series of loops (D, E, and F) from the complementary face of an adjacent subunit (40) , conforming to existing biochemical and mutational data on nAChRs. Based on the structure of the AChBP, nearly all the residues of the agonist-binding site of the nAChR that were previously identified by photoaffinity labeling and mutagenesis experiments are located in a small cavity of about 10 -12-Å diameter that is primarily formed by aromatic residues contributed by the participating subunits (10, 35, 41) .
6. The three-finger toxin scaffold: three fingers in many pies a-Neurotoxins from Elapid and Hydrophiid snake venoms belong to the three-finger toxin superfamily of non-enzymatic polypeptides containing 60 -74 amino acid residues. The characteristic feature of all threefinger toxins is their distinctive structure formed by three adjacent loops that emerge from a small, globular, hydrophobic core that is cross-linked by four conserved disulfide bridges (25, 42 -45) . The three loops that project from the core region resemble three outstretched fingers of the hand (Fig. 1) . The toxin is essentially a flat "leaf-like" molecule with a slight concavity, the plane being determined by the extensive multi-stranded b -structure that is the predominant feature (25, 44) .
In addition to the structural plasticity of the three fingers, the three-finger fold is also amenable to a variety of overt and subtle deviations, such as the number of b -strands present, size of the loops, and C-terminal tail as well as twists and turns of various loops, all of which may have great significance with respect to functional diversity and selectivity of molecular targets (25, 45) . Hence, despite the similar overall fold, three-finger toxins demonstrate an assorted range of pharmacological activities including, but not limited to, peripheral and central neurotoxicity, cyotoxicity, cardiotoxicity, inhibition of enzymes such as acetylcholinesterase and proteinases, hypotensive effect, and platelet aggregation (43 -46) .
In many instances, the functional sites of interaction between these pharmacologically diverse toxins and their molecular targets have been fairly accurately delineated and found to involve one or more different regions of the three-finger molecule (43 -45) . Hence it has been proposed that the "three-finger" scaffold is used by the snake to "hang" different combinations of functional groups, generating a panoply of target specificities (43, 47) . It thus appears that snakes adhere to a policy of structural economy by utilizing a limited number of molecular molds to achieve remarkable functional diversity. Furthermore, three-finger toxins are also among the simplest proteins that could be utilized to address essential questions about proteins in general, including protein-protein interactions, antigenic and immunogenic properties of proteins, folding processes, and the dynamic characteristics of proteins as well as offering an interesting molecular basis for the study of the evolution of protein folds (25).
Three-finger a-neurotoxins: a closer look at new angles
To date, more than 100 three-finger a-neurotoxins have been isolated and sequenced from Elapidae and Hydrophiidae snakes (42) . Depending on their amino acid sequence and/ or tertiary structures, a-neurotoxins can be classified into short-chain a -neurotoxins, longchain a-neurotoxins, atypical long-chain a-neurotoxins, and non-conventional three-finger neurotoxins (Table 1 and Fig. 3 ) (25, 48) . Although the primary molecular target of all these categories of three-finger neurotoxins appears to be the muscle-type nAChR, some toxins are also known to interact with other subtypes of nAChRs and in the case of some poorly characterized nonconventional toxins, it is possible that other unknown molecular targets may exist. Hence, while a classification of three-finger neurotoxins that interact with the muscle nAChR may be feasible from a purely structural stand-point, it must be remembered that a-neurotoxins are not a functionally homogenous group.
i. Short-chain and long-chain neurotoxins
Based on the length of their polypeptide chains, aneurotoxins were initially classified as short-chain aneurotoxins (e.g., erabutoxin-b; toxin-a (Naja nigricollis)) that have 60 -62 residues and four conserved disulfide bonds and long-chain a -neurotoxins (e.g., abungarotoxin and a -cobratoxin (Naja kaouthia)) with 66 -75 residues and five disulfide bonds, with the additional disulfide bridge located in the middle loop (loop II) (42) . Notwithstanding their classification as short-chain and long-chain neurotoxins, both types of aneurotoxins bind with high affinity (K d approximately 10 -9 -10 -11 M) to the Torpedo or muscle (a1) 2 b1gd
nAChRs (25) . Nonetheless, it has been reported that short-chain a -neurotoxins tend to associate with the nAChR 6 -7-fold faster and dissociate 5 -9-fold faster than long-chain a-neurotoxins (49). Apart from differences in structure, long-chain, but not short-chain, aneurotoxins are also able to bind with high affinity (K d approximately 10 -8 -10 -9 M) to neuronal homopentameric a 7, a8, and a 9 nicotinic receptors and well as to heteropentameric receptors composed of a7 -a 10 subunits (50 -52) .
ii. Atypical long-chain neurotoxins
Based on sequence homology to long-chain a -neurotoxins, the 69-residues-long neurotoxins isolated from the sea snake Laticauda semifasciata (Lc-a and Lc-b) (53) were also classified as long-chain toxins (42) . Like other prototype a -neurotoxins, both Lc-a and Lc-b, which differed from each other at only five positions in their sequences, showed high affinity for the Torpedo nAChR (K d approximately 10 -11 M) (50). However, Lc-a and Lc-b are atypical in the sense that, unlike the typical long-chain a -neurotoxins, they retain only the four conserved disulfide bridges and lack the fifth disulfide bridge at the tip of loop II (53) . Consequently, Lc-a and Lc-b bind poorly to neuronal a 7 nAChRs (25, 50).
iii. Non-conventional neurotoxins
The non-conventional toxins (48) constitute another class of three-finger toxins that consist of 62 -68 aminoacid residues and five disulfide bridges (e.g., candoxin Elapidae and Hydrophidae species. Typical examples include erabutoxin-a (Laticauda semifasciata), toxin-a (Naja nigricolis).
Long-chain neurotoxins
Three-fingered monomers of 66 -74 amino-acid residues with four conserved disulfide bonds and an additional disulfide bond at the tip of loop II.
High affinity for muscle or Torpedo (a1)2b1gd nAChR (Kd approximately 10 -9 -10 -11 M).
High affinity (Kd approximately 10 -8 -10 -9 M) antagonists of the neuronal a7 nAChR.
Isolated from Elapidae species. Typical examples include a-bungarotoxin (Bungarus multicinctus), a-cobratoxin (Naja kaouthia).
A typical long-chain neurotoxins
Three-fingered monomers of 69 amino-acid residues and four conserved disulfide bonds.
High affinity for Torpedo (a1)2b1gd nAChR (Kd approximately 10 -11 M).
Toxins Lc-a and Lc-b, isolated exclusively from Laticauda colubrina (Hydrophidae).
Non-conventional neurotoxins
Three-fingered monomers of 65 -67 amino-acid residues with four conserved disulfide bonds and an additional disulfide bond at the tip of loop I. and bucandin (Bungarus candidus)). However, unlike in long-chain a -neurotoxins and k-neurotoxins, the fifth disulfide bridge in non-conventional toxins is located in loop I (N-terminus loop) (Fig. 1) . Some studies have suggested that non-conventional toxins are typically characterized by a lower order of toxicity (LD 50 varying from approximately 5 -80 mg / kg) (25, 54) as opposed to prototype a -neurotoxins (LD 50 approximately 0.04 -0.3 mg / kg) (55) , and because of this, they are also referred to as weak toxins (54) . However, while some non-conventional toxins from cobra venoms (e.g., WTX (Naja kaouthia) (54) and Wntx-5 (Naja sputatrix) (56)) produced a weak inhibition of muscle (a1) 2 b1gd nAChRs in micromolar inhibitory concentrations, and candoxin from a krait venom (Bungarus candidus) was a potent inhibitor of muscle (a1) 2 b1gd nAChRs in low nanomolar (IC 50 approximately 10 nM) inhibitory concentrations (57) . In contrast to WTX and Wntx and in congruence with long-chain a -neurotoxins, candoxin was also found to inhibit neuronal a 7 nAChRs at low nanomolar (IC 50 approximately 50 nM) inhibitory concentrations (58) . Hence, it may be possible that some non-conventional toxins that bind weakly to muscle nAChRs may have other, yet unidentified, molecular targets.
Pharmacology of three-finger a-neurotoxins
i. In vitro assays for a-neurotoxin bioactivity a-Neurotoxins are potent competitive antagonists of the nAChRs at the skeletal muscle neuromuscular junction. Because the simultaneous occupation of both ligand-binding sites of the nAChR by agonists such as acetylcholine is required to elicit the conformational change that opens the gated ion-channel, the occupation of a single site by an antagonist a -neurotoxin is adequate to produce a non-functional receptor (2, 34, 35) . Skeletal muscle preparations from the chick (chick biventer cervicis muscle (59) ) and mouse (mouse phrenic nerve-hemidiaphragm (60)) provide simple but reliable in vitro organ bath assays for the examination of the effects of venoms and toxins on neuromuscular transmission (46, 61) . The chick biventer muscle in particular is useful to discriminate between presynaptic, postsynaptic, or myotoxic effects of neurotoxins since it contains both, focally and multiply innervated muscle fibers that, respectively, mediate twitch responses evoked by electrical nerve stimulation and contractile responses evoked by exogenous nAChR agonists such as acetylcholine and carbachol (57, 61, 62) (Fig. 4) .
Other screening methods for a -neurotoxin bioactivity include conventional binding experiments in which the competitive binding of a radio-labelled toxin to nAChRrich membranes from Torpedo electric organs is assayed and electrophysiological experiments where the ability of the toxin to inhibit currents or ion fluxes induced by agonists in nAChRs expressed in oocyte expression systems is studied (63) .
ii. Reversibility of a-neurotoxin neuromuscular blockade Although commonly referred to as "curaremimetic toxins", a-neurotoxins differ from (+)-tubocurarine in that the majority of a -neurotoxins, especially the longchain toxins, undergo almost irreversible binding to skeletal muscle nAChRs (9, 42, 49) . However, many a -conotoxins from marine cone-snails that interact with the nAChR (e.g., a -conotoxin MI and GI) are well known to produce reversible postsynaptic neuromuscular blockade in vitro and in vivo (64) . In sharp contrast to the poorly reversible nature of the a -neurotoxin-induced neuromuscular blockade, candoxin (Bungarus candidus) (57) and some weak neurotoxinhomologues (CM10, CM12 (Naja haje annulifera) and S 5 C 10 (Dendroaspis jamesoni)) (65) as well as toxin LSIII (Laticauda semifasciata) (66, 67) have been found to produce neuromuscular blockade that is rapidly and completely reversible.
It could be argued that the reversibility or irreversibility of neuromuscular blockade induced by toxins may just result from their weak or high binding affinity to the nAChRs. However, electrophysiological studies have revealed that a -bungarotoxin (IC 50 approximately 5 nM) produced an irreversible block of muscle (a 1) 2 b1gd receptors (68), whereas candoxin (IC 50 approximately 10 nM) produced a reversible blockade of the same receptor (58) . Furthermore, WTX (Naja kaouthia), a non-conventional toxin that is structurally similar to candoxin but a 1000-fold weaker antagonist of muscle nAChRs, is almost irreversible in its action (54) . Therefore, the reversibility of a -neurotoxin action at the neuromuscular junction is not always a reflection of their binding affinity to the receptor and may perhaps be associated with a specific area of interaction on the toxin molecule, distinct from the receptor recognition site (67) . For instance, in contrast to most a -neurotoxins, an aspartate at position 31 is absent in the neurotoxin-homologues CM10 and CM12, toxin LSIII as well as in candoxin, all of which were reported to be reversible in their action. It is possible that the absence of Asp 31 may be associated with easy reversibility of neuromuscular blockade produced by these toxins (57, 65) iii. Site-selectivity of a-neurotoxins
The existence of differences in the two binding sites of the nAChR has been attributed to the influence of the non-equivalent subunits (i.e., g, d , or e) on the conformation of the binding sites at their respective interfaces with the a1-subunit (69, 70). Many agonists and antagonists that interact with the muscle nAChR show some subunit selectivity that results in preferences for the a 1/ g or a 1 / d or a 1/ e interfaces (2, 71, 72). Conotoxin MI (Conus magus) that shows a 10,000-fold preference for the a 1 / d over the a 1/ g subunit interface in the mouse muscle nAChR (73, 74) and waglerin (Tropidolaemus wagleri) that shows a 2000-fold greater affinity for the a1/ e site over the a 1/ g or a1 / d sites in the mouse nAChR (7, 75) are excellent examples of the remarkable selectivity of peptide toxins.
Although most a -neurotoxins from snake venoms have not been found to exhibit ligand-binding site preference in the muscle nAChR, a short-chain a -neurotoxin from Naja mossambica mossambica (NmmI) shows an order of magnitude higher affinity for the a1/ g or a 1/ d interfaces (K d 140 pM) than for the a1 / e site (K d 130 nM), and this selectivity has been attributed to two residues (Pro 175 and Glu 176 ) in the g subunit of the nAChR (76) . Pharmacological studies on the nonconventional toxin candoxin (Bungarus candidus) also suggest that it may have differential affinity for the a1/ g or a1/ d interfaces of the muscle nAChR (57) . Furthermore, site-directed mutagenesis studies on a -cobratoxin revealed that the mutation of Lys 23 and Lys 49 to Glu 23 and Glu
49
, respectively, caused a differential lowering of binding affinity at the two binding sites of the muscle (a 1) 2 b1gd nAChRs (52). This observation was verified for NmmI, whereby the mutation of Lys 27 to Glu 27 affected binding at the a 1 / g site more than the a1 / d site (77) . Interestingly, position 29 in candoxin (homologous to Lys 23 in a-cobratoxin and Lys 27 in NmmI) is occupied by a glutamic acid instead of a lysine, suggesting a possible role for Glu 29 in conferring differential subunit selectivity (57).
Structure-function relationships of a-neurotoxins: what makes them tick? i. Structurally invariant residues in a-neurotoxins
The structures of almost all three-finger toxins including a -neurotoxins have conserved structurally invariant residues that are not involved in direct interaction with the respective target receptors of these toxins but, rather, contribute to the proper polypeptide chain folding and structural integrity of the polypeptide (42) . These include the eight cysteine residues that form the four conserved disulfide bridges located in the core region of the three-finger scaffold and constrain the three loops that protrude from it (42) . Tyr 25 or a homologous aromatic residue (Phe 27 ) is also conserved in most toxins that adopt a three-finger structure (Fig. 3) since it is required for proper folding of the polypeptide chain (78, 79) and the stability of the anti-parallel b-sheet structure of three-finger toxins (80) . The structurally invariant Gly 42 and Pro 48 residues are essential for maintaining the spatial conformation of a -neurotoxins (81) . Interestingly, some charged amino acid residues (e.g., Arg 39 in erabutoxin-a and Asp 60 in a -cobratoxin) have also been conserved in three-finger toxins for structural stability and have been reported to stabilize the native conformation of the protein by forming a salt links with the Cor N-terminus of the toxin (42) .
ii. Conformational determinants of structure-function of a-neurotoxins
The principal differences in the three-finger folds of short-chain and long-chain a-neurotoxins include the presence of an extra disulfide bridge at the tip of loop II, a longer C-terminus tail, and a shorter loop I in longchain toxins. These and other subtle structural deviations that exist between short-chain and long-chain a -neurotoxins often reflect some functional significance (43) . For instance, the high affinity binding of long-chain a-neurotoxins, but not short-chain a -neurotoxins, to neuronal a7 nAChRs has been clearly attributed to structural variations in loop II of the scaffold (50, 82) . Although the structure of three-finger a -neurotoxins is generally assumed to be devoid of a -helices (25, 44) , the fifth disulfide bridge present in long-chain a -neurotoxins (and k-neurotoxins) produces a cyclic "helixlike" conformation at the tip of loop II that consists of two sequential turns held in place by the disulfide bridge (Fig. 1) . This conformation has been reported to be crucial for their binding to their respective neuronal nAChR targets (50, 52, 83, 84) . Furthermore, NMR analysis of free a -bungarotoxin and a -bungarotoxin in complex with short cognate peptides of the nAChR toxin-binding region revealed that the cyclic conformation of the tip of loop II was a dynamic entity (85) . This flexibility of loop II would enable long-chain a -neurotoxins to accommodate substantial structural deviations and adopt alternate conformations in order to bind to diverse receptor subtypes (47, 86) .
Short-chain a -neurotoxins as well as atypical longchain toxins (Lc-a and Lc-b from Laticauda colubrina), which lack this fifth disulfide bridge and non-conventional toxins WTX (Naja kaouthia) and Wntx-5 (Naja sputatrix), both of which have the fifth disulfide bridge in loop I and lack the loop II helical conformation, have weak affinity, in micromolar concentrations (K d approximately 3 -22 mM) at best, for the neuronal a 7 nAChR (50, 54, 56) . Interestingly, candoxin (Bungarus candidus) is the first known toxin that lacks this critical helix-like conformation cyclized by the fifth disulfide bridge in loop II and yet blocks neuronal a 7 nAChRs in low nanomolar concentrations (58) . It is likely that candoxin utilizes other, yet undetermined, functional determinants in its interaction with the neuronal a 7 nAChR.
Molecular interactions: a toxin perspective
a-Neurotoxins utilize a common binding core to establish contacts with key invariant residues on the nAChR and other toxin-specific residues to interact with subtype-specific receptor residues (47) . Evidence for this came from exhaustive mutational analysis studies which revealed that short-chain and long-chain a -neurotoxins recognize the Torpedo or muscle (a1) (25) . In addition, each type of toxin also utilizes specific residues for receptor-recognition ( 
33
, and Lys 47 of loop II was independently verified by mutagenesis studies on another short-chain a -neurotoxin NmmI (Naja mossambica mossambica) (77) and by structural studies on the long-chain a -bungarotoxin (85, 89) . Furthermore, the functionally important residues for the Torpedo or muscle (a 1) 2 b 1gd receptor are all located on the concave surfaces of both short-chain and longchain a -neurotoxins with the most critical residue Arg 33 located at the very tip of loop II (Fig. 5 : D and F) (25, 88) .
Significantly, none of the residues in loop I of the long-chain toxin a-cobratoxin were found to be functionally important (52, 79) in contrast to the involvement of loop I in the short-chain toxin erabutoxin-a. Since loop I in a-cobratoxin is considerably shorter than that in erabutoxin-a, it is possible that this makes it inaccessible to the receptor surface and precludes its involvement in any interaction with the receptor (51) . Nonetheless, NMR studies have found that Thr 8 and Pro 10 in loop I of another long-chain toxin, a -bungarotoxin, appeared to interact with cognate peptides of the Torpedo nAChR containing the putative neurotoxin binding site (85, 90) . While the question remains as to whether this data could be extrapolated to represent toxin interaction with the intact nAChR, it could be argued that loop I of a -bungarotoxin, which is longer than that of a -cobratoxin by two residues, could indeed be long enough to be involved in receptor interaction (85) . Although residues in the C-terminus tails of acobratoxin (Phe 65 ) and a -bungarotoxin (Lys 70 and Arg 72 ) were found to be important for receptor interaction (52, 85) , the long-chain a-neurotoxin LSIII (Laticauda semifasciata) which has a short C-terminal tail ( Fig. 1:  F) was also found to bind with high affinity to the muscle nAChR, suggesting a minimal functional role for the characteristic long C-terminal of long-chain a -neurotoxins (50) .
The atypical long-chain a -neurotoxins Lc-a and Lc-b (Laticauda colubrina) retain most of the functionally important residues required for binding to muscle (a 1) 2 b1gd nAChRs (Fig. 6 ). However, of these key residues for the muscle receptor, only three (Lys 27 , Lys 47 , Arg 37 ) are present in homologous positions in nonconventional three-finger toxins from cobras (e.g., WTX (Naja kaouthia) and Wntx-5 (Naja sputatrix)) that showed weak interaction with muscle nAChRs. In contrast, the critical residues Trp 29 , Arg 33 , Arg
36
, Glu 38 , and Gly 34 are present at homologous positions in the primary sequence and in similar spatial disposition in the tertiary structure of candoxin (Fig. 6) (58) . Since conserved functionally important residues most likely have comparable binding function among neurotoxins (56) , this may explain the nanomolar affinity of candoxin for muscle and neuronal a7 nAChRs, not previously reported for any other non-conventional toxin (57).
Molecular interactions: a receptor perspective i. Insights from the molluscan acetylcholine binding protein
The remarkable structural and functional similarities between the molluscan acetylcholine binding protein and the amino-terminal ligand-binding domain of the nAChR enabled the construction of models of a -neurotoxins (a -cobratoxin or a -bungarotoxin) in complex with the receptor, incorporating established biochemical and mutagenesis data on a -neurotoxin-nAChR interactions (82, 85, 89, 91) . The model complexes clearly showed that a -neurotoxins bind perpendicularly to the receptor axis, with the tip of loop II plugging into the binding site of the receptor at the interface between two subunits and the C-terminal tails of a -cobratoxin and a -bungarotoxin as well as loop I of a -bungarotoxin Fig. 5 . A, B: Critical residues in erabutoxin-a and a-cobratoxin for the Torpedo (or muscle) nicotinic acetylcholine receptor. The 2.0-Å crystal structure of erabutoxin-a (5EBX) (A) and the 2.4-Å crystal structure of a -cobratoxin (2CTX) (B) showing the residues by which they interact with the Torpedo receptor. The Protein Data Bank accession codes are stated in parenthesis. Models based on data for erabutoxin-a (87, 102) and a-cobratoxin (79). The concave surfaces of the toxins are shown. The residues constituting the common binding core in both toxins are shown in red. The residues specific for each toxin are shown in dark green. In erabutoxin-a, the specific residues that have supplementary roles in the toxin-receptor interaction are shown in light green. The Corey-Pauling-Koltun space-filling molecular representation is presented. C, D: Critical residues in erabutoxin-a for the Torpedo (or muscle) nicotinic acetylcholine receptor. The concave surface (Corey-Pauling-Koltun representation) of erabutoxin-a (C) depicting the residues identified as playing crucial (red), important (green), and supplementary (blue) roles in binding to the muscle or Torpedo receptor as defined by affinity decreases of >100-fold, 10 -100-fold, and <10-fold, respectively. A side view of erabutoxin-a (a -carbon backbone structure) (D) showing the side chains of all the functionally important residues for interaction with the Torpedo receptor facing the concave surface. E, F: Critical residues in a-cobratoxin for the Torpedo (or muscle) nicotinic acetylcholine receptor. The residues in a-cobratoxin (Corey-Pauling-Koltun representation) (E) that constitute the common binding core (i.e., crucial for binding to both neuronal a7 and Torpedo receptors) are shown in red, whereas those specific for binding only to Torpedo receptors are shown in green. A side view of a-cobratoxin (a-carbon backbone structure) (F) showing the side chains of all the functionally important residues for interaction with the Torpedo receptor facing the concave surface.
making adjacent additional interactions at the receptor surface ( Fig. 7: A -C). The receptor was also shown to establish major contacts with the toxin principally via loop C, assisted by loops A and B of the principal (a 1) subunits as well as loops D and F of the complementary (g, d, or e) subunits (25, 41, 82, 86) (Fig. 7: D) . Furthermore, the a-neurotoxin is postulated to compete with acetylcholine by introducing the positive charge of Arg 33 located at the very tip of loop II into the ligandbinding pocket of the receptor, thereby simulating a "small ligand" that can plug into the cavity offered by the receptor interface (41, 82, 88) .
ii. Insights from nicotinic acetylcholine receptors of a-neurotoxin-resistant species
Comparative studies on muscle nAChRs of different animal species, such as those from the mongoose and cobra that are naturally resistant to the effects of aneurotoxins and those from the mouse and Torpedo ray which are sensitive, have also provided valuable information on toxin-receptor interactions (92 -94) . Collectively, these studies led to the definition of two subsites, an aromatic subsite that includes two aromatic residues at positions 187 and 189 and a proline subsite that includes Pro 194 and Pro 197 , in loop C of the ligandbinding domain of the a 1-subunit of the nAChR. Amino acid substitutions at these key positions (94) as well as N-linked glycosylation of loop C residues (e.g., Phe 189 ) (73, 95) are believed to confer a -neurotoxin resistance to the muscle nAChR of species resistant to snake envenomation.
iii. Insights from synthetic peptides derived from the nicotinic acetylcholine receptor Synthetic peptides have also been used to localize the a-neurotoxin binding sequences of the a 1-subunit of nAChRs (86, 96) . Collectively, these studies identified receptor segments coincident with loop C of the a 1-subunit of the nAChR as the primary a -neurotoxin binding site. (86) . Synthetic peptide binding studies also position the a-neurotoxin binding site in a homologous region on the neuronal a 7 nAChR (89, 97) .
Further important information about the structure of the loop C region of the nAChR has been gleaned from NMR and X-ray crystallography studies involving complexes between a -bungarotoxin and receptor peptides (86, 96) . These data found that the overall threefinger fold of a -bungarotoxin was preserved in the toxin-receptor peptide complex with conformational rearrangements occurring at the tips of loops I and II and the C-terminus tail. The complexes also revealed a snug fit of the peptide to the toxin, with the bound peptide adopting a b-hairpin conformation that resembled the corresponding loop region in the molluscan acetylcholine binding protein (41, 91) . This permitted the superimposition of the toxin-peptide complex onto a model of the acetylcholine binding protein and, by analogy, visualizes the interaction between a -neurotoxins and the nAChR. The receptor peptides were found to bind between toxin loops I and II with the tip of loop I interfacing with the receptor peptide residue homologous to the aromatic residue at position 189 of the a 1-subunit loop C (86) . Furthermore, four positively charged residues in the toxin (Arg 36 and Lys 38 (loop II) Fig. 6 . Functionally invariant residues in three-finger neurotoxins that interact with muscle nicotinic acetylcholine receptors. Amino-acid sequences of representative short-chain a-neurotoxins, long-chain a-neurotoxins, atypical long-chain neurotoxins, and non-conventional three-finger toxins showing the distribution of residues critical for binding to muscle (a1)2b 1gd nicotinic acetylcholine receptors (shaded in grey). Figure is based on mutational experimental data for erabutoxin-a (87, 102) and acobratoxin (79) and structural data for a-bungarotoxin (85, 89) . Since conserved functionally important residues are likely to have comparable binding function among neurotoxins, the putative functional residues in candoxin, WTX, Lc-a, and Lc-b are also shown. The species names and Protein Data Bank accession numbers are as for Fig. 3 . The cysteine residues are in bold lettering and the disulfide linkages and the segments contributing to the three loops and C-terminus tail are outlined.
and Lys 70 and Arg 72 (C-terminus tail)) are in close apposition with highly conserved aromatic residues (Trp
187

, Tyr
189
, Tyr
190 ) in the a 1-subunit, suggesting that cation-p interactions may be involved in the formation of the receptor-toxin complex (85).
Three-finger a-neurotoxins as pharmacological probes: old dogs, new tricks
Since the advent of a-bungarotoxin as a pharmacological probe to dissect the biology of the nAChR, a wide array of three-finger a -neurotoxin derivatives including radioactive, fluorescent, and biotinylated conjugates have been developed and are commercially available (47) . In addition, the functional blockade produced by a -neurotoxins is also useful in characterizing nAChR ligands in pharmacological and electrophysiological studies. Apart from these well-defined and much exploited roles, a -neurotoxins from snake venoms have recently been the focus of novel experimental strategies.
A new facet in toxinology evolved with efforts to obtain synthetic peptides that bind a -neurotoxins with high affinity. This venture began with the identification of a 13-residues-long lead-peptide from a combinatorial phage-display library that inhibited the binding of abungarotoxin with low-micromolar affinity (98) . A new peptide library was then designed based on systematic 1, d , g , and e subunits of the muscle nicotinic acetylcholine receptor and the a7 subunit of the neuronal a7 nicotinic receptor showing the amino acid residues involved in binding a-neurotoxins. In the muscle receptor, loops A, B, and C belong to the a1 subunit, whereas loops D, E, and F belong to the adjacent complementary d, g , or e subunit. In the neuronal a7 receptor, loops A, B, and C belong to the principal binding face and loops D, E, and F belong to the complementary binding face of the a7 subunit. Residues that interact with short-chain (bold), long-chain (bold and underlined), or both types of a-neurotoxins (bold and shaded in grey) are shown (numbered as in the mouse muscle nAChR). Data based on Refs. 10, 35, and 82.
single residue replacement followed by rational multiple residue replacement of amino acids in the library-leadpeptide (96) . Some of these high-affinity peptides were better inhibitors (IC 50 approximately 2 nM) of abungarotoxin binding to muscle nAChR than analogous peptides derived from natural amino acid sequences of the muscle nAChR. Interestingly, in preliminary in vivo studies, the high-affinity peptides injected into mice were capable of neutralizing the toxicity of a -bungarotoxin, suggesting that this approach may eventually yield potentially useful antidotes for neurotoxin envenomation (99) . The approach of creating high affinity peptides by "systematic residue replacement" may also be applied as a general method for the design and synthesis of high-affinity peptides in any biochemical system that involves a ligand and a receptor molecule (96) .
The scope of a -neurotoxins as molecular probes was enhanced by the demonstration that a neuronal a3 subunit of the nAChR, normally insensitive to a -neurotoxin blockade, could be converted to an a -neurotoxinsensitive receptor (IC 50 approximately 20 -40 nM) by the exchange of just five residues in its loop C with the corresponding residues from the a -bungarotoxinsensitive neuronal a 7 nAChR (100). More recently, this procedure has also been carried out with success on non-a subunits of the nAChR (86) . Likewise, and more generally, it may be possible to introduce a -bungarotoxin sensitive sites ("pharmatopes") into other nonacetylcholine receptors and membrane proteins, thereby permitting the use of various a -neurotoxin tags to localize and isolate and characterize new receptor subtypes (86) . The development of synthetic mimotype peptides that bind a-bungarotoxin with greater affinities than peptides derived from native nAChR sequences (96) may provide even more sensitive "pharmatopes" that could be introduced into proteins of interest with the aim of creating high affinity toxin-binding sites that allow novel experimental access to a -neurotoxin probes (86) .
The ingenuity of snakes in utilizing a common threefinger protein scaffold to produce toxins with a wide array of pharmacological functions offers an exemplary example for protein engineering (43, 45) . Using the same principle, toxins with new pharmacological properties can be engineered by providing the threefinger scaffold with a novel, customized binding property (47) . For example, the functional residues of fasciculin 2, an anti-acetylcholinesterase toxin with a three-finger structure (17) , have been transferred to homologous positions of a host short-chain a -neurotoxin creating a chimera that lost its nAChR binding properties but acquired anti-acetylcholinesterase activity comparable to the donor toxin (101) . With this success, it is now possible to generate rationally designed novel activities on toxin scaffolds, ab initio, opening the doors to the development of mini-proteins of therapeutic value (47).
Conclusions: not the last word yet
The past forty years or so, with the molecular and genomic revolutions to its credit, have seen remarkable progress being made in our scientific prowess. Along with the flow, our understanding of the structure and function of both a -neurotoxins and the nAChR, as well as the interaction between the two, has vastly improved to the atomic level. The amino acid residues by which the toxin molecule binds to the receptor and the sites by which the receptor interacts with the toxin have largely been delineated. These data reveal the intricacy and remarkable plasticity of the three-finger toxin fold that have optimally evolved to interact with specific molecular targets with precision capable of discerning subtle differences in just a few amino acid residues between receptor subtypes and high affinity that is often many fold greater than the affinity of the natural ligand for that receptor. Three-finger a -neurotoxins are also ideal candidates to address essential questions about proteins in general, including protein-protein interactions, as well as offering an interesting molecular basis about the evolution of protein scaffolds. Data gleaned from the a-neurotoxin -nAChR interaction can also be extrapolated to other members of the ligand-gated ion channel superfamily including GABA A , serotonin 5-HT 3 , and glycine receptors, making this field of study all the more important for neurobiology in general. a -Neurotoxins and other biogenic molecules from animal venoms have already established themselves as key players in scientific discovery and medicine as ultra-selective pharmacological probes as well as lead compounds for drug discovery. With the advent of novel technologies and discovery of new toxins, it is not presumptuous to envisage more ambitious strategies for protein engineering and design of scientific probes and therapeutic molecules by exploiting the natural potential of animal toxins.
